DXCM250103P82000
- 4.45
- 0.000.00%
DexCom Newsroom
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $86
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $115
RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Wells Fargo Spotlights 31 Names It Believes 'Offer Above-average Growth Potential'
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Santa Claus Came Without Rallying the Troops | Live Stock
Chevron, PayPal Stock and These 8 US Names Are Best Ideas for Q1 2025 at BofA
These Are the Best and Worst Stocks This Year
DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Earnings Tell The Story For DexCom, Inc. (NASDAQ:DXCM)
Weekly Buzz: So far, Santa is Letting us Down